Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up-Reference-Cited by-同舟云学术

Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up

Published:2017-01 Issue:1 Volume:39 Page:34-41
ISSN:1701-2163
Container-title:Journal of Obstetrics and Gynaecology Canada
language:en
Short-container-title:Journal of Obstetrics and Gynaecology Canada

Author:

Bouchard-Fortier Geneviève,Panzarella Tony,Rosen Barry,Chapman William,Gien Lilian T.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference33 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer;Int J Gynaecol Obstet,2003

3. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer;Heintz;Int J Gynaecol Obstet,2006

4. Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor;Bamias;Eur J Cancer,2012

5. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma;Madore;J Pathol,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation;International Journal of Gynecologic Cancer;2024-08-19

2. Radical total pelvic exenteration with concomitant right nephrectomy in the management of recurrent endometrioid ovarian adenocarcinoma: A case report and literature review;Clinical Case Reports;2024-07

3. Endometrioid ovarian carcinoma landscape: pathological and molecular characterization;Molecular Oncology;2024-06-25

4. Ovarian Endometrioid and Clear-Cell Tumors;Gynecologic and Obstetric Pathology;2024

5. Effect of tumor type on response to adjuvant platinum-based chemotherapy and prognosis in patients with stage II–IV epithelial ovarian carcinoma;Ginekologia Polska;2023-09-01